Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

Recruiting now · Not applicable

Conditions studied: Intracranial Artery Stenosis

In brief

sICASBLM is a prospective controlled trial, to asses the impact of improving blood lipid management on clinical outcome of moderate to severe symptomatic intracranial atherosclerotic stenosis patients (LDL-C\>1.8mmol/L) without endovascular therapy.

Key facts

Study ID
NCT05397405
Run by
Nanjing First Hospital, Nanjing Medical University
People needed
180
Starts
2022-05-23
Expected to finish
2026-05-01
Last updated by the study team
2026-04-15

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.